NO20043396L - Kortikotropinfrigjorende faktorreseptor 2-agonister - Google Patents

Kortikotropinfrigjorende faktorreseptor 2-agonister

Info

Publication number: NO20043396L
Authority: NO; Norway
Prior art keywords: corticotropin; agonists; factor receptor; releasing factor; releasing
Prior art date: 2002-01-16

Application number

NO20043396A

Other languages

English (en)

Inventor

Robert Joseph Isfort

Wieslaw Adam Mazur

Original Assignee

Procter & Gamble

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-01-16

Filing date

2004-08-16

Publication date

2004-10-06

2004-08-16 Application filed by Procter & Gamble filed Critical Procter & Gamble

2004-10-06 Publication of NO20043396L publication Critical patent/NO20043396L/no

Links

108091005470 CRHR2 Proteins 0.000 title 1
102100038019 Corticotropin-releasing factor receptor 2 Human genes 0.000 title 1
239000000556 agonist Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/57509—Corticotropin releasing factor [CRF] (Urotensin)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Gastroenterology & Hepatology (AREA)
Neurology (AREA)
Molecular Biology (AREA)
Physical Education & Sports Medicine (AREA)
Toxicology (AREA)
Zoology (AREA)
Orthopedic Medicine & Surgery (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Pain & Pain Management (AREA)
Diabetes (AREA)
Immunology (AREA)
Epidemiology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

NO20043396A 2002-01-16 2004-08-16 Kortikotropinfrigjorende faktorreseptor 2-agonister NO20043396L (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US34911702P	2002-01-16	2002-01-16
US37633702P	2002-04-29	2002-04-29
US38889502P	2002-06-14	2002-06-14
US41198802P	2002-09-19	2002-09-19
PCT/US2003/001454 WO2003062277A1 (en)	2002-01-16	2003-01-16	Corticotropin releasing factor receptor 2 agonists

Publications (1)

Publication Number	Publication Date
NO20043396L true NO20043396L (no)	2004-10-06

Family

ID=27617822

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
NO20043371A NO20043371L (no)	2002-01-16	2004-08-13	Kortikotropinfrigjorendefaktorreseptor-2 agonister
NO20043366A NO20043366L (no)	2002-01-16	2004-08-13	Kortikotropinfrigjorende faktor-2 reseptoragonister
NO20043396A NO20043396L (no)	2002-01-16	2004-08-16	Kortikotropinfrigjorende faktorreseptor 2-agonister

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
NO20043371A NO20043371L (no)	2002-01-16	2004-08-13	Kortikotropinfrigjorendefaktorreseptor-2 agonister
NO20043366A NO20043366L (no)	2002-01-16	2004-08-13	Kortikotropinfrigjorende faktor-2 reseptoragonister

Country Status (29)

Country	Link
US (7)	US6936585B2 (no)
EP (4)	EP1465923B1 (no)
JP (3)	JP4489434B2 (no)
KR (3)	KR100758857B1 (no)
CN (3)	CN1617887A (no)
AR (3)	AR038143A1 (no)
AT (4)	ATE362488T1 (no)
AU (2)	AU2003205197B2 (no)
BR (3)	BR0306826A (no)
CA (3)	CA2470731C (no)
CY (1)	CY1106133T1 (no)
DE (4)	DE60307044T2 (no)
DK (2)	DK1465923T3 (no)
ES (4)	ES2309909T3 (no)
IL (5)	IL162530A0 (no)
MA (3)	MA27591A1 (no)
MX (3)	MXPA04006885A (no)
MY (1)	MY140306A (no)
NO (3)	NO20043371L (no)
NZ (3)	NZ533599A (no)
PE (3)	PE20030974A1 (no)
PL (3)	PL371364A1 (no)
PT (2)	PT1465921E (no)
RU (1)	RU2294333C2 (no)
SA (3)	SA03230564B1 (no)
SI (1)	SI1465921T1 (no)
TW (3)	TWI300442B (no)
WO (3)	WO2003062268A2 (no)
ZA (1)	ZA200404995B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002024732A2 (en) *	2000-09-22	2002-03-28	Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften	Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US6936585B2 (en) *	2002-01-16	2005-08-30	The Procter & Gamble Company	Corticotropin releasing factor 2 receptor agonists
WO2005103690A2 (en) *	2004-04-24	2005-11-03	Bayer Healthcare Ag	Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 2 (crhr2)
EP1871888A4 (en) *	2005-03-30	2013-08-21	Novartis Vaccines & Diagnostic	HAEMOPHILUS INFLUENZAE OF TYPE B
WO2007090087A2 (en) *	2006-01-27	2007-08-09	Research Development Foundation	Use of corticotropin releasing factor receptor-2 inhibitors for treating insulin-related diseases
WO2009046874A1 (en) *	2007-09-11	2009-04-16	Mondobiotech Laboratories Ag	Therapeutic combination of trh-potentiating peptide and stresscopin
KR20100056507A (ko) *	2007-09-11	2010-05-27	몬도바이오테크 래보래토리즈 아게	치료제로서의 펩티드 ｐｒｏ－ｇｌｙ－ｔｈｒ－ｃｙｓ－ｇｌｕ－ｉｌｅ－ｃｙｓ－ａｌａ－ｔｙｒ－ａｌａ－ａｌａ－ｃｙｓ－ｔｈｒ－ｇｌｙ－ｃｙｓ의 용도
EP2190533A2 (en) *	2007-09-11	2010-06-02	Mondobiotech Laboratories AG	Use of a peptide as a therapeutic agent
CN102272151B (zh)	2008-11-04	2014-08-20	詹森药业有限公司	Crhr2肽激动剂及其用途
EP2206726A1 (en) *	2009-01-08	2010-07-14	Universite Joseph Fourier	Non-invasive tools for detecting vulnerable atherosclerotic plaques
US20110105397A1 (en) *	2009-11-04	2011-05-05	Gengo Peter J	Method for treating heart failure with stresscopin-like peptides
US9314506B2 (en)	2011-10-24	2016-04-19	Research Development Foundation	Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
CA2864100A1 (en)	2012-02-14	2013-08-22	The Regents Of The University Of California	Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions
JOP20170153A1 (ar)	2016-07-15	2019-01-30	Lilly Co Eli	نظائر urocortin-2 جديدة معدلة بحمض دهني لعلاج داء السكري وأمراض الكلى المزمنة
KR20190084055A (ko) *	2016-10-20	2019-07-15	코르텐 인코포레이티드	부적응 스트레스 반응에서 기인한 질환의 치료 방법
CN110755434B (zh) *	2018-07-27	2022-03-15	中国医学科学院药物研究所	化合物palosuran防治骨骼肌萎缩等疾病的用途
WO2025184558A1 (en) *	2024-02-28	2025-09-04	Caradon Therapeutics, Inc.	Modified urocortin 3
TW202544027A (zh) *	2024-04-19	2025-11-16	美商紐羅克里生物科學有限公司	促皮質素釋放因子受體２（ｃｒｆｒ２）促效劑
WO2025230248A1 (ko) *	2024-04-30	2025-11-06	한미약품 주식회사	Crf2 수용체 작용제와 그 아실화 결합체의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5235036A (en) *	1991-05-31	1993-08-10	The Salk Institute For Biological Studies	Crf analogs
EP0860501A3 (en)	1994-06-14	1999-05-19	Neurocrine Biosciences, Inc.	Corticotropin-releasing factor2 receptors
US5786203A (en) *	1994-06-14	1998-07-28	Neurocrine Biosciences, Inc.	Isolated nucleic acid encoding corticotropin-releasing factor2 receptors
US5824771A (en)	1994-12-12	1998-10-20	The Salk Institute For Biological Studies	Cyclic CRF agonists
US5663292A (en) *	1994-12-12	1997-09-02	The Salk Institute For Biological Studies	Cyclic CRF analogs
US5660824A (en)	1995-05-24	1997-08-26	Grabstein; Kenneth H.	Muscle trophic factor
CA2223792A1 (en)	1995-06-13	1997-01-03	The Salk Institute For Biological Studies	Urocortin peptides
US5869450A (en) *	1996-03-06	1999-02-09	The Regents Of The University Of California	Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
WO2002012307A1 (en)	2000-08-04	2002-02-14	Research Development Foundation	Urocortin proteins and uses thereof
WO2002024732A2 (en) *	2000-09-22	2002-03-28	Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften	Methods for improving the antagonistic/agonistic properties of peptidic antagonists/agonists of the corticotropin-releasing factor receptor (crfr)
US20020082409A1 (en)	2000-10-26	2002-06-27	Hsu Sheau Yu	Stresscopins and their uses
US6670140B2 (en) *	2001-03-06	2003-12-30	The Procter & Gamble Company	Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
US6936585B2 (en) *	2002-01-16	2005-08-30	The Procter & Gamble Company	Corticotropin releasing factor 2 receptor agonists

2002
- 2002-12-11 US US10/317,252 patent/US6936585B2/en not_active Expired - Lifetime
- 2002-12-11 US US10/315,964 patent/US7192923B2/en not_active Expired - Fee Related
- 2002-12-11 US US10/317,251 patent/US7192924B2/en not_active Expired - Fee Related
2003
- 2003-01-10 TW TW092100533A patent/TWI300442B/zh not_active IP Right Cessation
- 2003-01-10 TW TW092100535A patent/TW200302278A/zh unknown
- 2003-01-10 TW TW092100532A patent/TW200302276A/zh unknown
- 2003-01-14 PE PE2003000040A patent/PE20030974A1/es not_active Application Discontinuation
- 2003-01-14 PE PE2003000041A patent/PE20030849A1/es not_active Application Discontinuation
- 2003-01-14 PE PE2003000039A patent/PE20030747A1/es not_active Application Discontinuation
- 2003-01-15 MY MYPI20030136A patent/MY140306A/en unknown
- 2003-01-15 AR ARP030100100A patent/AR038143A1/es unknown
- 2003-01-15 AR ARP030100101A patent/AR038144A1/es unknown
- 2003-01-15 AR ARP030100099A patent/AR038142A1/es unknown
- 2003-01-16 KR KR1020047011052A patent/KR100758857B1/ko not_active Expired - Fee Related
- 2003-01-16 SI SI200330360T patent/SI1465921T1/sl unknown
- 2003-01-16 AT AT03731965T patent/ATE362488T1/de not_active IP Right Cessation
- 2003-01-16 NZ NZ533599A patent/NZ533599A/en unknown
- 2003-01-16 JP JP2003562154A patent/JP4489434B2/ja not_active Expired - Fee Related
- 2003-01-16 DE DE60307044T patent/DE60307044T2/de not_active Expired - Lifetime
- 2003-01-16 ES ES06117810T patent/ES2309909T3/es not_active Expired - Lifetime
- 2003-01-16 WO PCT/US2003/001451 patent/WO2003062268A2/en not_active Ceased
- 2003-01-16 CA CA2470731A patent/CA2470731C/en not_active Expired - Fee Related
- 2003-01-16 BR BR0306826-9A patent/BR0306826A/pt not_active IP Right Cessation
- 2003-01-16 DE DE60318547T patent/DE60318547T2/de not_active Expired - Lifetime
- 2003-01-16 CN CNA038023709A patent/CN1617887A/zh active Pending
- 2003-01-16 DE DE60321730T patent/DE60321730D1/de not_active Expired - Lifetime
- 2003-01-16 AU AU2003205197A patent/AU2003205197B2/en not_active Ceased
- 2003-01-16 BR BR0306838-2A patent/BR0306838A/pt not_active Application Discontinuation
- 2003-01-16 ES ES03703867T patent/ES2269976T3/es not_active Expired - Lifetime
- 2003-01-16 CA CA2470656A patent/CA2470656C/en not_active Expired - Fee Related
- 2003-01-16 AU AU2003237419A patent/AU2003237419B2/en not_active Ceased
- 2003-01-16 PL PL03371364A patent/PL371364A1/xx unknown
- 2003-01-16 MX MXPA04006885A patent/MXPA04006885A/es active IP Right Grant
- 2003-01-16 KR KR1020047011051A patent/KR100735586B1/ko not_active Expired - Fee Related
- 2003-01-16 DE DE60313845T patent/DE60313845T2/de not_active Expired - Lifetime
- 2003-01-16 JP JP2003562146A patent/JP4508649B2/ja not_active Expired - Fee Related
- 2003-01-16 AT AT03731963T patent/ATE383372T1/de not_active IP Right Cessation
- 2003-01-16 EP EP03731965A patent/EP1465923B1/en not_active Expired - Lifetime
- 2003-01-16 NZ NZ533600A patent/NZ533600A/en unknown
- 2003-01-16 JP JP2003562145A patent/JP4508648B2/ja not_active Expired - Fee Related
- 2003-01-16 EP EP06117810A patent/EP1724283B1/en not_active Expired - Lifetime
- 2003-01-16 IL IL16253003A patent/IL162530A0/xx unknown
- 2003-01-16 MX MXPA04006883A patent/MXPA04006883A/es active IP Right Grant
- 2003-01-16 DK DK03731965T patent/DK1465923T3/da active
- 2003-01-16 WO PCT/US2003/001461 patent/WO2003062269A2/en not_active Ceased
- 2003-01-16 MX MXPA04006884A patent/MXPA04006884A/es active IP Right Grant
- 2003-01-16 PT PT03703867T patent/PT1465921E/pt unknown
- 2003-01-16 IL IL15252903A patent/IL162529A0/xx unknown
- 2003-01-16 EP EP03703867A patent/EP1465921B1/en not_active Expired - Lifetime
- 2003-01-16 EP EP03731963A patent/EP1465922B1/en not_active Expired - Lifetime
- 2003-01-16 PL PL03373529A patent/PL373529A1/xx not_active Application Discontinuation
- 2003-01-16 NZ NZ533598A patent/NZ533598A/en unknown
- 2003-01-16 WO PCT/US2003/001454 patent/WO2003062277A1/en not_active Ceased
- 2003-01-16 CN CNB038023520A patent/CN100475844C/zh not_active Expired - Fee Related
- 2003-01-16 RU RU2004124847/13A patent/RU2294333C2/ru active
- 2003-01-16 ES ES03731965T patent/ES2287484T3/es not_active Expired - Lifetime
- 2003-01-16 ES ES03731963T patent/ES2299701T3/es not_active Expired - Lifetime
- 2003-01-16 PT PT03731965T patent/PT1465923E/pt unknown
- 2003-01-16 AT AT06117810T patent/ATE398632T1/de not_active IP Right Cessation
- 2003-01-16 IL IL16243103A patent/IL162431A0/xx unknown
- 2003-01-16 DK DK03703867T patent/DK1465921T3/da active
- 2003-01-16 CN CNB038023644A patent/CN100391972C/zh not_active Expired - Fee Related
- 2003-01-16 KR KR1020047011057A patent/KR100758858B1/ko not_active Expired - Fee Related
- 2003-01-16 BR BR0306878-1A patent/BR0306878A/pt not_active IP Right Cessation
- 2003-01-16 CA CA2470743A patent/CA2470743C/en not_active Expired - Fee Related
- 2003-01-16 PL PL03373139A patent/PL373139A1/xx not_active Application Discontinuation
- 2003-01-16 AT AT03703867T patent/ATE334147T1/de not_active IP Right Cessation
- 2003-03-01 SA SA3230564A patent/SA03230564B1/ar unknown
- 2003-03-01 SA SA03230564D patent/SA03230564A/ar unknown
- 2003-03-01 SA SA3230565A patent/SA03230565B1/ar unknown
2004
- 2004-06-24 ZA ZA2004/04995A patent/ZA200404995B/en unknown
- 2004-07-13 MA MA27779A patent/MA27591A1/fr unknown
- 2004-07-13 MA MA27780A patent/MA27592A1/fr unknown
- 2004-07-13 MA MA27778A patent/MA27590A1/fr unknown
- 2004-08-13 NO NO20043371A patent/NO20043371L/no not_active Application Discontinuation
- 2004-08-13 NO NO20043366A patent/NO20043366L/no not_active Application Discontinuation
- 2004-08-16 NO NO20043396A patent/NO20043396L/no not_active Application Discontinuation
2005
- 2005-05-04 US US11/121,612 patent/US7462597B2/en not_active Expired - Fee Related
2006
- 2006-07-28 CY CY20061101051T patent/CY1106133T1/el unknown
2007
- 2007-02-02 US US11/701,576 patent/US7608701B2/en not_active Expired - Fee Related
- 2007-02-02 US US11/701,912 patent/US7632933B2/en not_active Expired - Fee Related
2009
- 2009-01-07 IL IL196384A patent/IL196384A0/en unknown
- 2009-03-24 IL IL197774A patent/IL197774A0/en unknown
- 2009-10-26 US US12/605,718 patent/US7897731B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO20043371L (no)	2004-10-06
RU2004124847A (ru)	2005-04-20
PE20030747A1 (es)	2003-10-23
BR0306878A (pt)	2004-10-26
NZ533600A (en)	2007-02-23
KR20040082389A (ko)	2004-09-24
HK1078095A1 (zh)	2006-03-03
AR038143A1 (es)	2004-12-29
CA2470743C (en)	2011-12-13
SA03230564B1 (ar)	2006-10-31
US20100197579A1 (en)	2010-08-05
US7192923B2 (en)	2007-03-20
IL196384A0 (en)	2011-07-31
ES2287484T3 (es)	2007-12-16
DE60307044T2 (de)	2007-02-15
EP1724283A3 (en)	2007-04-11
US7632933B2 (en)	2009-12-15
SA03230565B1 (ar)	2006-10-31
PL371364A1 (en)	2005-06-13
PL373529A1 (en)	2005-09-05
NO20043366L (no)	2004-10-06
JP2005521387A (ja)	2005-07-21
AR038144A1 (es)	2004-12-29
US7897731B2 (en)	2011-03-01
CN1617887A (zh)	2005-05-18
EP1465922B1 (en)	2008-01-09
JP4489434B2 (ja)	2010-06-23
RU2294333C2 (ru)	2007-02-27
TW200302278A (en)	2003-08-01
US20030148956A1 (en)	2003-08-07
WO2003062277A1 (en)	2003-07-31
ATE362488T1 (de)	2007-06-15
EP1465923B1 (en)	2007-05-16
DE60307044D1 (de)	2006-09-07
AU2003205197B2 (en)	2006-03-02
US20030148958A1 (en)	2003-08-07
US20080004435A1 (en)	2008-01-03
DE60321730D1 (de)	2008-07-31
US7462597B2 (en)	2008-12-09
ZA200404995B (en)	2005-06-29
ES2269976T3 (es)	2007-04-01
BR0306826A (pt)	2005-09-06
CA2470656A1 (en)	2003-07-31
KR20040082390A (ko)	2004-09-24
DK1465923T3 (da)	2007-07-02
ATE398632T1 (de)	2008-07-15
DK1465921T3 (da)	2006-11-27
CY1106133T1 (el)	2011-06-08
IL162529A0 (en)	2005-11-20
DE60313845T2 (de)	2008-01-31
DE60313845D1 (de)	2007-06-28
CN100391972C (zh)	2008-06-04
MA27590A1 (fr)	2005-11-01
PL373139A1 (en)	2005-08-22
AR038142A1 (es)	2004-12-29
US7608701B2 (en)	2009-10-27
PE20030974A1 (es)	2003-12-26
ES2299701T3 (es)	2008-06-01
MY140306A (en)	2009-12-31
CA2470731C (en)	2011-06-21
ES2309909T3 (es)	2008-12-16
JP4508648B2 (ja)	2010-07-21
IL162530A0 (en)	2005-11-20
NZ533599A (en)	2007-03-30
SA03230565A (ar)	2005-12-03
TW200302277A (en)	2003-08-01
CA2470731A1 (en)	2003-07-31
DE60318547T2 (de)	2008-12-24
PT1465923E (pt)	2007-08-06
BR0306838A (pt)	2005-04-05
IL162431A0 (en)	2005-11-20
WO2003062269A2 (en)	2003-07-31
AU2003237419B2 (en)	2006-04-13
TWI300442B (en)	2008-09-01
CA2470656C (en)	2011-06-28
US20030148957A1 (en)	2003-08-07
CN1617885A (zh)	2005-05-18
EP1465921B1 (en)	2006-07-26
KR100758857B1 (ko)	2007-09-14
US20060025339A1 (en)	2006-02-02
WO2003062268A2 (en)	2003-07-31
IL197774A0 (en)	2009-12-24
CN100475844C (zh)	2009-04-08
US7192924B2 (en)	2007-03-20
CN1617886A (zh)	2005-05-18
MXPA04006883A (es)	2004-12-06
US20090124793A1 (en)	2009-05-14
EP1465923A1 (en)	2004-10-13
US6936585B2 (en)	2005-08-30
SI1465921T1 (sl)	2006-10-31
JP2005525101A (ja)	2005-08-25
JP2005522191A (ja)	2005-07-28
JP4508649B2 (ja)	2010-07-21
EP1465922A2 (en)	2004-10-13
ATE334147T1 (de)	2006-08-15
MA27592A1 (fr)	2005-11-01
WO2003062268A3 (en)	2003-11-27
EP1465921A2 (en)	2004-10-13
SA03230564A (ar)	2005-12-03
EP1724283B1 (en)	2008-06-18
PE20030849A1 (es)	2003-12-01
MXPA04006885A (es)	2004-12-06
NZ533598A (en)	2007-03-30
KR20040082392A (ko)	2004-09-24
ATE383372T1 (de)	2008-01-15
DE60318547D1 (de)	2008-02-21
KR100735586B1 (ko)	2007-07-04
CA2470743A1 (en)	2003-07-31
PT1465921E (pt)	2006-12-29
MXPA04006884A (es)	2004-12-06
WO2003062269A3 (en)	2003-11-06
TW200302276A (en)	2003-08-01
KR100758858B1 (ko)	2007-09-14
MA27591A1 (fr)	2005-11-01
EP1724283A2 (en)	2006-11-22

Legal Events

Date	Code	Title	Description
2010-08-23	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
DK1446379T3 (da)	2009-07-27	Arylanilin-beta2-adrenergiske receptoragonister
DE60330392D1 (de)	2010-01-14	Cb 1 rezeptor inversagonisten
NO20043396L (no)	2004-10-06	Kortikotropinfrigjorende faktorreseptor 2-agonister
DE60308850D1 (de)	2006-11-16	Pyridinoylpiperidine als 5-ht1f agonisten
ATE388937T1 (de)	2008-03-15	Agonisten des cannabinoidrezeptors
FI20030006A7 (fi)	2003-07-08	Yhteiskäyttöverkko
ATE384053T1 (de)	2008-02-15	Triazolderivate als tachykininrezeptor- antagonisten
IS7607A (is)	2004-12-21	Ný útskipt indól
NO20023424L (no)	2002-09-10	Kortikotropin-frigjörende faktorantagonister
DE60308670D1 (de)	2006-11-09	Substituierte indole als alpha-1 agonisten
DE10393374D2 (de)	2005-09-01	Zusammensetzung
NO20044046L (no)	2004-11-15	Substituerte hydroksyetylaminer
EP1544279A4 (en)	2007-03-07	LUBRICANT COMPOSITION
EP1559433A4 (en)	2009-11-04	STABILIZED COMPOSITION
DK1561472T3 (da)	2013-11-11	Faststofsammensætning
NO20034497D0 (no)	2003-10-08	Somatostatin agonister
EP1559771A4 (en)	2007-02-14	FAT COMPOSITION
DE60321822D1 (de)	2008-08-07	Monocyclopentadienylkomplexe
ATE496887T1 (de)	2011-02-15	Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
SE0500163L (sv)	2005-01-24	Sammansättning
DE60324018D1 (de)	2008-11-20	Agonisten
DK1487778T3 (da)	2012-08-06	Substituerede 4 aminocyclohexanoler
NO20044337L (no)	2004-10-12	Faststoff-dispergeringspreparat
NO20016259D0 (no)	2001-12-20	Trosse
DE60319277D1 (de)	2008-04-03	Beschichtungszusammensetzung